Topics

Daratumumab Becomes Treatment Staple in Newly Diagnosed Multiple Myeloma

09:44 EST 14 Feb 2020 | OncLive

The foremost choice in the treatment of patients with newly diagnosed multiple myeloma is determining whether a patient is eligible for transplant, as that choice will set the stage for all future decisions.

Original Article: Daratumumab Becomes Treatment Staple in Newly Diagnosed Multiple Myeloma

NEXT ARTICLE

More From BioPortfolio on "Daratumumab Becomes Treatment Staple in Newly Diagnosed Multiple Myeloma"

Quick Search

Relevant Topic

Transplantation
Organ transplantation is the moving of an organ from one body to another or from a donor site to another location on the patient's own body, for the purpose of replacing the recipient's damaged or absent organ. The emerging field of regenerative ...